Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder
CONCLUSIONS: CT may reduce the subjective aversive effects of THC, potentially leading to greater cannabis use in individuals with OUD.SCIENTIFIC SIGNIFICANCE: These findings offer insights into THC's risks versus benefits in OUD subgroups and emphasize assessing CT in OUD treatment and research.PMID:38059660 | DOI:10.1111/ajad.13504 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - December 7, 2023 Category: Addiction Authors: Michael Rogan Julio C Nunes Catherine Z Xie Mehmet Sofuoglu Brian Pittman Joao P De Aquino Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs
CONCLUSIONS: The treatment of individuals with OUD using fentanyl with a rapid 1-day induction to BUP-XR 300 mg injection is feasible and well-tolerated.SCIENTIFIC SIGNIFICANCE: A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.PMID:37936553 | DOI:10.1111/ajad.13484 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - November 8, 2023 Category: Addiction Authors: John J Mariani Robert L Dobbins Amy Heath Frank Gray Howard Hassman Source Type: research
